Blood pressure-independent atherogenic and thromboembolic mechanisms of the renin-angiotensin-aldosterone system

Journal of Clinical and Basic Cardiology

Volumn 4, Issue 2, 2001, Pages 89-91

  Lottermoser, K ^a   Vetter, H ^a   Dusing R ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Atherosclerosis; Fibrinolysis; Growth factors; Renin angiotensin system; Thromboembolism

Indexed keywords

CYTOKINE; GROWTH FACTOR;

APOPTOSIS; ATHEROGENESIS; BLOOD PRESSURE REGULATION; CELL PROLIFERATION; EXTRACELLULAR FLUID; FIBRINOLYSIS; GENE DELETION; GENETIC POLYMORPHISM; HUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY; THROMBOEMBOLISM; VASCULAR SMOOTH MUSCLE;

EID: 0034838251     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (54)

1. Angiotensin-converting enzyme inhibition and vascular remodeling in coronary artery disease
2. Essential hypertension, renin and aldosterone, heart attack and stroke
3. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension
4. Plasma renin activity: A risk factor for myocardial infarction in hypertensive patients
5. The D/I polymorphism of the ACE gene and cardiovascular-renal risk
6. Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease
7. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
8. The pathogenesis of atherosclerosis: Atherogenesis and inflammation
9. Atherosclerosis: An inflammatory disease
10. Regional accumulations of T-cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque
11. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis
12. Angiotensin induces inflammatory activation of human vascular smooth muscle cells
13. Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: Effects of enalapril
14. Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans
15. Mechanism of protective effects of ACE inhibition on coronary artery disease
16. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner
17. Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits
18. Elevated levels of interleukin-6 in unstable angina
19. Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells
20. VCAM-1 on activated endothelium interacts with the leucocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
21. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats
22. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells
23. Effect of beta(2)adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells
24. Vascular cell-adhesion molecule-1 (VCAM-1) gene-transcription and expression are regulated through an antioxidant sensitive mechanism in human vascular endothelial cells
25. Angiotensin II type 1 receptor blockade prevents upregulation of angiotensin II type 1. A receptors in rat injured artery
26. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
27. Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo
28. Angiotensin II inhibits interleukin-1 beta-induced nitric oxide production in cultured rat mesangial cells
29. Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
30. Effects of captopril on atherosclerosis in cynomolgus monkeys
31. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril
32. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system
33. Cellular biology of blood vessels
34. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells
35. Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells
36. Cross-talk between angiotensin II and interleukin-6-induced signalling through STAT3 transcription factor
37. The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist
38. Hormonal regulation of cardiac fibroblast function
39. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells
40. 1 receptors in cultured human cardiac fibroblasts
41. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells
42. 1-receptor blockade
43. Molecular and cellular mechanism of angiotensin II-mediated apoptosis
44. 2 receptor inhibits proliferation and promotes differentiation in PC12W cells
45. 2-receptor mediates inhibition of coronary endothelial cells
46. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin 11 type 1 receptor action: An in vitro gene transfer study
47. Angiotensin II regulates the expression of plasminogen activator inhibitor-I in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis
48. The effect of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells
49. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II
50. Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin
51. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1
52. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque
53. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls